Hearing on “Direct-To-Consumer Genetic Testing and the Consequences to the Public Health," Subcommittee on Oversight and Investigations (July 22, 2010)

Subcommittee on Oversight and Investigations (111th Congress)
Jul 22, 2010

The Subcommittee on Oversight and Investigations held a hearing entitled “Direct-To-Consumer Genetic Testing and the Consequences to the Public Health,” on Thursday, July 22, 2010, in 2123 Rayburn House Office Building.  The hearing examined the sale of direct-to-consumer personal genetic tests.

Documents

 

Witnesses

  • Gregory Kutz, Managing Director, Forensic Audits and Special Investigations, Government Accountability Office
  • Jeff Shuren, M.D., J.D., Director, Center for Devices and Radiological Health, Food and Drug Administration
  • James Evans, M.D., Ph.D., Editor-in-Chief, Genetics in Medicine; Bryson Professor of Genetics and Medicine, University of North Carolina at Chapel Hill
  • Ashley Gould, General Counsel, 23andMe, Inc.
  • Vance Vanier, M.D., President and Chief Executive Officer, Navigenics, Inc.
  • David Becker, Ph.D., Chief Scientific Officer, Pathway Genomics Corporation

 

Testimony

 

Webcast

Undercover contact with Direct-to-Consumer Genetic Testing Companies
Video presented during the testimony of Gregory Kutz

 

Hearing Video

Key Documents: 
111th Congress